Your Location: Set Your Location
See services nearest you.
Essentia Health Menu
Home > Education & Research > Research to Improve Health Care > Participating in Research > Clinical Trials > Clinical Trials Details
Back to Results
Venous thromboembolic complications, such as deep vein thrombosis and pulmonary embolism, are significantly increased in trauma patients. Enoxaparin is the most proven prophylactic treatment in trauma patients. However, Essentia Health-St. Mary’s Medical Center (EH-SMMC) trauma quality data indicates the use of different forms of prophylaxis other than enoxaparin for several patient groups that are at higher risk for venous thromboembolism (VTE). EH-SMMC patient population has a high number of elderly trauma patients with many comorbidities, which may complicate the choice of prophylaxis. The purpose of this retrospective study is to evaluate the current use of venous thromboembolic prophylaxis at EH-SMMC to identify areas of improvement in patient care, especially for the patient groups that are not receiving prophylaxis in accordance with trauma guidelines. The study will identify rates of VTE and risk factors for VTE in subsets of trauma patients, and identify patient groups that may be adequately treated with other means of prophylaxis.
Dr. Kristin Colling is the Principal Investigator. Melissa Harry, PhD, and Jennifer Hoff, RN, are Co-Investigators.